Infantile Spasms Therapeutics Market Globally Grow At A CAGR Of 10.16% During The Period 2017 – 2021

ResearchMoz presents this most up-to-date research on “Infantile Spasms Therapeutics Market Globally Grow At A CAGR Of 10.16% During The Period 2017 – 2021”.

An infantile spasm is a particular type of seizure found in an epilepsy syndrome of infancy and childhood. It is also known as a West syndrome. The onset of infantile spasm is usually found in the first year of life between four months and eight months of age. The condition constitutes 2% of childhood epilepsies and 25% of epilepsies with onset in the first year of life. There are around 2,000-4,000 new cases observed in the US each year. The overall long-term prognosis for infantile spasms patients is poor. It has been found that 50%-70% of infantile spasms patients develop other seizure types and 18%-50% will develop LennoxGastaut syndrome (LGS) or other forms of symptomatic generalized epilepsy.

Technavios analysts forecast the global infantile spasms therapuetics market to grow at a CAGR of 10.16% during the period 2017-2021.

Covered in this report 
The report covers the present scenario and the growth prospects of the global thoracic surgery market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of infantile spasms therapuetics.

The market is divided into the following segments based on geography: 
Americas
APAC
EMEA

Technavio’s report, Global Infantile Spasms Therapeutics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
H. Lundbeck
Mallinckrodt Pharmaceuticals
INSYS Therapeutics

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=915036

Other prominent vendors 

Anavex Life Sciences
Catalyst Pharmaceuticals
GW Pharmaceuticals
ORPHELIA Pharma
Retrophin
Valerion Therapeutics

Market driver 
Major drugs launch expected in 2017-2021
For a full, detailed list, view our report

Market challenge 
Growing usage of seizure management devices, a threat to drug therapies
For a full, detailed list, view our report

Market trend 
Development of devices and smartphone apps to detect seizures and track medications
For a full, detailed list, view our report

Key questions answered in this report 
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=915036

%d bloggers like this: